about
Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleusInhibition of 5α-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activationGating deficits in isolation-reared rats are correlated with alterations in protein expression in nucleus accumbens.Could ADMA levels in young adults born preterm predict an early endothelial dysfunction?Differential distribution of VGF-derived peptides in the adrenal medulla and evidence for their selective modulation.On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons?NMDARs mediate the role of monoamine oxidase A in pathological aggression.Prematurity and low weight at birth as new conditions predisposing to an increased cardiovascular risk.Nitrergic system and plasmatic methylarginines: Evidence of their role in the perinatal programming of cardiovascular diseases.Advanced intrauterine growth restriction is associated with reduced excretion of asymmetric dimethylarginine.Clinical metabolomics and hematic ADMA predict the future onset of cardiorenal syndrome in young grown-up subjects who were born preterm.Urinary NGAL and hematic ADMA levels: an early sign of cardio-renal syndrome in young adults born preterm?Endodontic infection and endothelial dysfunction are associated with different mechanisms in men and women.Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex.Lead intoxication during intrauterine life and lactation but not during adulthood reduces nucleus accumbens dopamine release as studied by brain microdialysis.Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex.Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal.Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study.Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic.Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex.Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex.Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex.Association of endodontic infection with detection of an initial lesion to the cardiovascular system.Isolation rearing-induced reduction of brain 5α-reductase expression: relevance to dopaminergic impairments.6-Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex.The dopamine beta-hydroxylase inhibitor nepicastat increases dopamine release and potentiates psychostimulant-induced dopamine release in the prefrontal cortex.Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex.Antagonism by abecarnil of enhanced acetylcholine release in the rat brain during anticipation but not consumption of food.Inhibition of basal and stress-induced dopamine release in the cerebral cortex and nucleus accumbens of freely moving rats by the neurosteroid allopregnanolone
P50
Q24806184-119AC129-988E-49F9-AEBF-FC3D3A417155Q30463310-E103B50B-AD71-45E9-BEAC-12CA1ECC9732Q33389360-06C3C539-6771-4410-A4DB-B81CD6751EA1Q33850714-511828DA-7325-4D71-A298-1FBD90C9E505Q34773956-C4DAD765-748A-41EE-B4BD-015432177084Q34794235-89095E52-CFDE-4F9E-A911-BBECCA25985FQ36158709-6A3D46AB-9FE2-4FD5-ACBE-2BFB233A7618Q37985798-32DE8FE9-E278-44ED-93CC-BC0A013A3B93Q38500310-0F480E07-24D8-4157-9BBF-523712B53964Q39254941-71C29441-BD28-4460-A9B5-2FB3D9BC2A23Q39299462-FADF7537-7703-4543-8469-5A52AC2DB9D2Q39344760-49491FCB-8CEC-47FA-9CA4-47DDDC591B00Q41177596-7ECD8D12-01C4-4ED9-921B-F3F786D1F0CEQ42458877-E041D233-7338-4767-A466-A0C5110F4BAAQ42487390-A77B851B-50D5-4CE2-A67E-A29E31A8C25DQ43615218-89ACE778-134E-4690-AA5B-EF3B9E24C58CQ43775304-DA3B868F-998E-45D6-8E20-CCBB84941847Q43903580-80AC31C2-C180-480D-BCF4-4CF4FA0EC514Q44182591-7C207178-A390-441F-A2C6-AEE6E058A5A1Q44359160-A6974DA9-F0A8-451E-97BD-C58891AB997AQ44600266-910CF9B2-6654-4671-8FDA-0718FD4FDCACQ44751648-6E618119-BB4B-4F7A-9E71-85F41A4D1EB3Q45233014-7C5BDF73-D2CF-47CE-95CE-728C49346F95Q45711167-0BC4BCAA-6B0B-4E36-9CC3-1EB8975E2BF3Q46069030-F7FF7A24-9FAB-4856-BC97-93AE84099025Q46812498-B5022214-2D80-4F81-998D-68037ABFCF1BQ48101589-EB9C2C32-3CC2-4E6A-BEBD-7F8B2C12BA43Q48236604-3AA55E5C-9F69-40FE-92DC-37BB0D5AF073Q48505920-CCEA9D5A-27C0-46F9-AC39-119D410220F1Q60935513-CD6B347B-CA76-48FE-8A44-FFB4D1778250
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giovanna Flore
@ast
Giovanna Flore
@en
Giovanna Flore
@es
Giovanna Flore
@nl
Giovanna Flore
@sl
type
label
Giovanna Flore
@ast
Giovanna Flore
@en
Giovanna Flore
@es
Giovanna Flore
@nl
Giovanna Flore
@sl
prefLabel
Giovanna Flore
@ast
Giovanna Flore
@en
Giovanna Flore
@es
Giovanna Flore
@nl
Giovanna Flore
@sl
P106
P21
P31
P496
0000-0003-2560-8613